Indications
Nimotop (active ingredient: nimodipine) is a prescription medication indicated for:
- Subarachnoid Hemorrhage: Nimotop is used to improve neurological outcomes by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms, regardless of their post-ictus neurological condition.
Nimotop belongs to a class of drugs known as calcium channel blockers, which work by inhibiting calcium ions from entering smooth muscle cells and neurons, leading to vasodilation and improved blood flow in the brain, thereby reducing the risk of cerebral vasospasm and associated neurological deficits following subarachnoid hemorrhage.
Uses and Dosage
Nimotopcomes in tablet form and should be used as soon as possible after the onset of bleeding in the brain, typically within 4 days. It should be taken as directed by your doctor, usually every 4 hours, with a full glass of water (8 ounces/240 milliliters), but you should not lie down for at least 10 minutes after taking the tablet.
Nimodipine should start as early as possible or within 96 hours of the diagnosis of subarachnoid hemorrhage. The recommended dose for adults is 60 mg (two 30-mg capsules) every 4 hours for 21 consecutive days.
Do not crush the tablet and avoid consuming grapefruit or grapefruit juice while using this medication, as it may increase the risk of side effects. Always follow your doctor's instructions carefully when taking Nimotop.
Side Effects
Common Side Effects of Nimotop (Nimodipine):
- Low blood pressure (feeling lightheaded)
- Muscle pain
- Nausea
- Slow heartbeats
- Upset stomach
Serious Side Effects of Nimotop (Nimodipine):
- Hives
- Difficulty breathing
- Swelling of your face, lips, tongue, or throat
- Lightheadedness
- Fast or slow heart rate
- Swelling or your ankles or feet
Form and Strength
Nimotop (Nimodipine) is available in the following forms and strength:
Nimodipine: Tablet
- 30 mg
Caution
- Nimotop should not be administered by parenteral routes (injection)
- Caution is required in patients with hypotension (low blood pressure)
- Blood pressure should be carefully monitored during treatment with Nimotop.
- Nimotop may interact with other drugs, so patients should inform their doctor of all drugs they are taking, including prescription, nonprescription, and herbal products.
- Patients should avoid consuming grapefruit or grapefruit juice while taking Nimotop, since it may increase the risk of side effects.
- Nimotop may cause dizziness or fainting, so patients should avoid activities requiring alertness.
- Nimotop can cause dizziness, so patients should use caution when driving or operating heavy machinery until they know how the medication affects them.
- Nimotop may cause allergic reactions and other serious side effects, so patients should seek medical attention if they experience symptoms such as difficulty breathing, swelling of the face or tongue, or chest pain.
Frequently Asked Questions (FAQ)
When is the best time to take nimodipine?
It must be given at least 1 hour before or 2 hours after meals.
Should nimodipine be taken with food?
It is best to take this medicine at least 1 hour before or 2 hours after a meal.
Can Nimotop be used to prevent strokes or other conditions?
Nimotop is specifically indicated for the treatment of vasospasm following subarachnoid hemorrhage and is not intended for use in preventing strokes or any other conditions.
How long does it usually take for Nimotop to start working?
The onset of action for Nimotop can vary depending on several factors, including the patient's individual response, the dosage and formulation, and the severity of the condition being treated. Patients should consult with their healthcare provider for guidance on what to expect during treatment with Nimotop.
REVIEWS